You are here:

azithromycin (Zedbac)

Advice

following an abbreviated submission:

azithromycin (Zedbac®) is accepted for use within NHS Scotland.

Indication under review: the treatment of community acquired pneumonia (CAP) and pelvic inflammatory disease (PID) due to susceptible organisms in adult patients where initial intravenous therapy is required.

Consideration should be given to official guidance regarding the appropriate use of antibacterial agents.

This is the first intravenous formulation of azithromycin to be made available in the UK.

The intravenous formulation is significantly more expensive than the oral preparation of azithromycin, but it is intended only for short-term use and on the advice of local microbiologists or specialists in infectious diseases.
 

Drug Details

Drug Name: azithromycin (Zedbac)
SMC Drug ID: 950/14
Manufacturer: Aspire Pharma Ltd
Indication: The treatment of community acquired pneumonia (CAP) and pelvic inflammatory disease (PID) due to susceptible organisms in adult patients where initial intravenous therapy is required.
BNF Category:
Sub Category: 5.1 Antibacterial drugs
Submission Type: Abbreviated Submission
Status: Accepted
Date Advice Published: 7 April 2014

Back